NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
July 15, 2019
A business unit of Wilmington-based global contract research organization PPD is launching a five-year study involving 30,000 people throughout the U.S. age 50 and older, to explore ways to prevent and treat dementia.
July 12, 2019
The BIO World Congress on Industrial Biotechnology and Ag Tech will bring industry thought leaders to North Carolina in 2020, for the first time, a recognition that Raleigh is at the heart of the global ag tech revolution.
July 10, 2019
Grifols’ product portfolio just got a little larger with U.S. Food and Drug Administration approval of Xembify, a treatment for immune deficiency.
July 10, 2019
Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, has received an industry award and signed a group purchasing agreement for its asthma products.
July 8, 2019
North Carolina entrepreneurs on the prowl for equity funding will get some professional help this Thursday, July 11, as the North Carolina Biotechnology Center hosts the Small Business and Technology Development Center’s "Becoming an Investor-Ready Entrepreneur" program.
July 4, 2019
ViiV Healthcare, a global HIV company with U.S. headquarters in RTP, gets EU okay to begin marketing its once-daily Dovato, previously approved for the U.S.
June 28, 2019
North Carolina is ready to lead in military medical technology, said Scott Dorney, head of the NC Military Business Center, to attendees at the 2019 Warfighter symposium in Chapel Hill.
June 28, 2019
RTP's CivaTech Oncology has some rare good news about pancreatic cancer.
June 28, 2019
Navigating the maze of 20 different organizations that approve military technology projects for funding can be daunting. The 2019 Support to the Warfighter Symposium speakers offered some roadmaps for submitting successful project proposals.
June 26, 2019
Milestone Pharmaceuticals, a Montreal company with a growing Charlotte subsidiary, has something in development that investors like: a nasal spray called Etripamil, in Phase 3 clinical trials to treat a form of heart arrhythmia.
June 26, 2019
Climate held sway at this year's annual Ag Tech Professional Forum Summer Social, where like-minded people networked and learned.
June 25, 2019
In speculating about the future of agriculture, David Hollinrake, president of Syngenta Seeds and North America region director, is certain of one thing: “It’s not going to be my daddy’s farm moving forward.”
June 25, 2019
SNP Therapeutics, an innovative Charlotte-area company, is merging high-tech genomic testing with personalized nutritional formulations to treat individual medical conditions.
June 24, 2019
Durham’s Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine of China have announced a collaboration to develop and commercialize Mycovia’s drug candidate for treating recurrent yeast infections in women.
June 20, 2019
Some of the Piedmont Triad’s most successful individuals and organizations working in the biosciences were honored with Excellence Awards at Triad BioNight.